Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 25% in 1 yearIf the volatility the street is witnessing today is bothering you, just remember: Market breadth is looking good. Volatility is part of eve...
Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 30% in 1 yearWith the US entering the Israel-Iran war, geopolitical uncertainty just went up a couple of notches. As we have said often, there is no poi...
Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 40%When should one be cautious, in a strong trending bullish market which has lasted for months or bearish markets? The answer is both, in cas...
Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising ...
Second & better attempt; 5 Indian pharma stocks with upside potential of up to 31%Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performa...
After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...
Lupin gets USFDA nod to market generic drug for treatment of lung diseaseLupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the Amer...
Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...
On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...
On a path to recovery; 5 mid-cap pharma stocks with an upside potential up to 41%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in bearish markets. Some of them are mid-sized Ind...
6 midcaps that have beaten bearish & volatile markets can rise up to 42%, suggest analystsOnce again the US banks are at the center of a storm in equity markets. In such times, a few mid-cap stocks have been able to keep their he...
Midcaps with long term perspective; 9 stocks with high ROE & net profit marginMany investors, especially the ones sitting on cash are confused about what they should do with their existing stocks – buy the dip or not....
On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...